Skip to Main Content

An official website of the United States government

About this Publication
Title
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations.
Pubmed ID
28025329 (View this publication on the PubMed website)
Digital Object Identifier
Publication
Hum. Mol. Genet. 2017 Jan 15; Volume 26 (Issue 2): Pages 454-465
Authors
Seow WJ, Matsuo K, Hsiung CA, Shiraishi K, Song M, Kim HN, Wong MP, Hong YC, Hosgood HD, Wang Z, Chang IS, Wang JC, Chatterjee N, Tucker M, Wei H, Mitsudomi T, Zheng W, Kim JH, Zhou B, Caporaso NE, ...show more Albanes D, Shin MH, Chung LP, An SJ, Wang P, Zheng H, Yatabe Y, Zhang XC, Kim YT, Shu XO, Kim YC, Bassig BA, Chang J, Ho JC, Ji BT, Kubo M, Daigo Y, Ito H, Momozawa Y, Ashikawa K, Kamatani Y, Honda T, Sakamoto H, Kunitoh H, Tsuta K, Watanabe SI, Nokihara H, Miyagi Y, Nakayama H, Matsumoto S, Tsuboi M, Goto K, Yin Z, Shi J, Takahashi A, Goto A, Minamiya Y, Shimizu K, Tanaka K, Wu T, Wei F, Wong JY, Matsuda F, Su J, Kim YH, Oh IJ, Song F, Lee VH, Su WC, Chen YM, Chang GC, Chen KY, Huang MS, Yang PC, Lin HC, Xiang YB, Seow A, Park JY, Kweon SS, Chen CJ, Li H, Gao YT, Wu C, Qian B, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Tsai YH, Jung YJ, Guo H, Hu Z, Wang WC, Chung CC, Lawrence C, Burdett L, Yeager M, Jacobs KB, Hutchinson A, Berndt SI, He X, Wu W, Wang J, Li Y, Choi JE, Park KH, Sung SW, Liu L, Kang CH, Hu L, Chen CH, Yang TY, Xu J, Guan P, Tan W, Wang CL, Sihoe AD, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chan JK, Chu M, Li YJ, Li J, Chen H, Yu CJ, Jin L, Lo YL, Chen YH, Fraumeni JF, Liu J, Yamaji T, Yang Y, Hicks B, Wyatt K, Li SA, Dai J, Ma H, Jin G, Song B, Wang Z, Cheng S, Li X, Ren Y, Cui P, Iwasaki M, Shimazu T, Tsugane S, Zhu J, Jiang G, Fei K, Wu G, Chien LH, Chen HL, Su YC, Tsai FY, Chen YS, Yu J, Stevens VL, Laird-Offringa IA, Marconett CN, Lin D, Chen K, Wu YL, Landi MT, Shen H, Rothman N, Kohno T, Chanock SJ, Lan Q
Affiliations
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
  • Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
  • Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
  • National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
  • Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, People's Republic of China.
...show more
  • Division of Thoracic Surgery, Kinki University School of Medicine, Sayama, Japan.
  • Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Department of Integrative Bioscience & Biotechnology, Sejong University, Seoul, Republic of Korea.
  • Department of Epidemiology, School of Public Health, China Medical University, Shenyang, People's Republic of China.
  • Guangdong Lung Cancer Institute, Medical Research Center and Cancer Center of Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China.
  • Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Central Hospital, Nagoya, Japan.
  • Department of Thoracic and Cardiovascular Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lung and Esophageal Cancer Clinic, Chonnam National University Hwasun Hospital, Hwasun-eup, Republic of Korea.
  • Department of Etiology & Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong.
  • Laboratory for Genotyping Development, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
  • Center for Antibody and Vaccine Therapy, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Division of Epidemiology & Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan.
  • Department of Medical Oncology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Department of Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Kanagawa, Japan.
  • Department of Thoracic Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
  • Division of Translational Research, Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Chiba, Japan.
  • Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.
  • Department of Thoracic Oncology, National Cancer Center Hospital East, Japan.
  • Department of Cellular and Organ Pathology.
  • Department of Thoracic Surgery, Graduate School of Medicine, Akita University, Akita City, Japan.
  • Department of Integrative Center of General Surgery, Gunma University Hospital, Gunma, Japan.
  • Department of Occupational and Environmental Health and Ministry of Education Key Lab for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • China National Environmental Monitoring Center, Beijing, People's Republic of China.
  • Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Internal Medicine, Division of Oncology/Hematology, College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Department of Clinical Oncology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
  • Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • School of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Division of Pulmonary Medicine, Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Department of Internal Medicine, Kaohsiung Medical University Hospital, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Epidemiology, Shanghai Cancer Institute, Shanghai, People's Republic of China.
  • Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
  • Lung Cancer Center, Kyungpook National University Medical Center, Daegu, Republic of Korea.
  • Genomic Research Center, Academia Sinica, Taipei, Taiwan.
  • Department of Etiology & Carcinogenesis and State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Cancer Research Center, Kyungpook National University Medical Center, Daegu, Republic of Korea.
  • Division of Pulmonary and Critical Care Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
  • Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, People's Republic of China.
  • The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Westat, Rockville, MD, USA.
  • Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Department of Health Sciences Research.
  • Cancer Prevention Institute of California, Fremont, CA, USA.
  • Department of Thoracic and Cardiovascular Surgery, Seoul St Mary's Hospital, The Catholic University of Korea, Republic of Korea.
  • Department of Oncology, Cancer Center, Union Hospital, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Ministry of Education Key Laboratory of Modern Toxicology.
  • Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • School of Public Health, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.
  • Department of Pulmonary and Critical Care, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Department of Surgery, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.
  • Division of Medical Oncology, Department of Internal Medicine, College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Department of Oncology, Wuhan Iron and Steel (Group) Corporation Staff-Worker Hospital, Wuhan, People's Republic of China.
  • Chest Department, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Division of Environmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands.
  • Agency for Integrated Care, Singapore.
  • Department of Pathology, Queen Elizabeth Hospital, Hong Kong, People's Republic of China.
  • Qujing Center for Diseases Control and Prevention, Qujing, People's Republic of China.
  • Department of Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Jinan, People's Republic of China.
  • Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
  • Shanghai Pulmonary Hospital, Shanghai, People's Republic of China.
  • Laboratory Services, American Cancer Society, Atlanta, GA, USA.
  • Department of Surgery, Department of Biochemistry and Molecular Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Abstract

To evaluate associations by EGFR mutation status for lung adenocarcinoma risk among never-smoking Asian women, we conducted a meta-analysis of 11 loci previously identified in genome-wide association studies (GWAS). Genotyping in an additional 10,780 never-smoking cases and 10,938 never-smoking controls from Asia confirmed associations with eight known single nucleotide polymorphisms (SNPs). Two new signals were observed at genome-wide significance (P < 5 × 10-8), namely, rs7216064 (17q24.3, BPTF), for overall lung adenocarcinoma risk, and rs3817963 (6p21.3, BTNL2) which is specific to cases with EGFR mutations. In further sub-analyses by EGFR status, rs9387478 (ROS1/DCBLD1) and rs2179920 (HLA-DPB1) showed stronger estimated associations in EGFR-positive compared to EGFR-negative cases. Comparison of the overall associations with published results in Western populations revealed that the majority of these findings were distinct, underscoring the importance of distinct contributing factors for smoking and non-smoking lung cancer. Our results extend the catalogue of regions associated with lung adenocarcinoma in non-smoking Asian women and highlight the importance of how the germline could inform risk for specific tumour mutation patterns, which could have important translational implications.

Related CDAS Studies
Related CDAS Projects